Pharmaceutical
Pharmaceutical Formulations
Related Pages
American Council On Pharmaceutical Education
American Pharmaceutical Partners
Generic Pharmaceutical Industry
Journal Of Pharmaceutical Science
Pharmaceutical Bottles
Pharmaceutical Calculations
Pharmaceutical Chemicals
Pharmaceutical Company Ontario
Pharmaceutical Conference
Pharmaceutical Costs
Pharmaceutical Drug Index
Pharmaceutical Engineering
Pharmaceutical Filtration
Pharmaceutical Formulations
Pharmaceutical Industry Profile
Pharmaceutical Machinery Manufacturer
Pharmaceutical Marketing Congress
Pharmaceutical Organization
Pharmaceutical Patient Assistance Program
Pharmaceutical Price
Pharmaceutical Pricing
Pharmaceutical Product Management
Pharmaceutical Project Management
Pharmaceutical Recall
Pharmaceutical Rep Salary
Pharmaceutical Sales Average Salary
Pharmaceutical Sales Job Description
Pharmaceutical Spokesperson
Pharmaceutical Supplier
Pharmaceutical Technologies
Pharmaceutical Terminology
Pharmaceutical Water
Pharmaceutical Writer
Sample Pharmaceutical Sales Resume
The Pharmaceutical Journal
West Pharmaceutical Services
Elite Pharmaceuticals, Inc. to Discuss Second Quarter 2012 Results of Operati
bi13282073
NORTHVALE, N.J. -- Elite s, Inc. , a specialty company dedicated to developing and commercializing oral sustained and controlled release product formulations and generics ..
CFR Pharmaceuticals investing $27.0 million Uman Pharma Inc. (Candiac, Can
bi13282073
CANDIAC, QC, Nov. 10, 2011 /PRNewswire/ - Uman Pharma Inc., a Canadian privately owned generic company pleased to announce the conclusion of a strategic partnership CFR s S. A. (CFR) of Santiago, Chile. As part of transaction CFR acquired a..
Malvern specialist presents nasal spray analysis at Indian Pharmaceutical Ass
bi13282073
Dr Paul Kippax, Product Group Manager at Malvern Instruments, speak at the Indian Association's (IPA) 5th Symposium on Nasal and Pulmonary Drug Delivery at Juhu, Mumbai, India 10-11 November 2011. Malvern a gold sponsor of the event and also conduct a workshop on using the Spraytec laser diffraction analyzer to characterize aerosols
K-V Pharmaceutical Announces Updated MakenaŽ Performance Metrics
bi13282073
ST. LOUIS, Nov. 8, 2011 /PRNewswire/ -- K-V Company (NYSE: KV.A/ KV.B) (the "Company" or "K-V"), today reported updated performance metrics for MakenaŽ, the only U.S. Food & Drug Administration ("FDA") approved product indicated to reduce the risk of preterm birth..
Elite Pharmaceuticals, Inc. to Discuss Second Quarter 2012 Results of Operati
bi13282073
NORTHVALE, N.J. -- Elite s, Inc. , a specialty company dedicated to developing and commercializing oral sustained and controlled release product formulations and generics ..
CFR Pharmaceuticals investing $27.0 million Uman Pharma Inc. (Candiac, Can
bi13282073
CANDIAC, QC, Nov. 10, 2011 /PRNewswire/ - Uman Pharma Inc., a Canadian privately owned generic company pleased to announce the conclusion of a strategic partnership CFR s S. A. (CFR) of Santiago, Chile. As part of transaction CFR acquired a..
Malvern specialist presents nasal spray analysis at Indian Pharmaceutical Ass
bi13282073
Dr Paul Kippax, Product Group Manager at Malvern Instruments, speak at the Indian Association's (IPA) 5th Symposium on Nasal and Pulmonary Drug Delivery at Juhu, Mumbai, India 10-11 November 2011. Malvern a gold sponsor of the event and also conduct a workshop on using the Spraytec laser diffraction analyzer to characterize aerosols
K-V Pharmaceutical Announces Updated MakenaŽ Performance Metrics
bi13282073
ST. LOUIS, Nov. 8, 2011 /PRNewswire/ -- K-V Company (NYSE: KV.A/ KV.B) (the "Company" or "K-V"), today reported updated performance metrics for MakenaŽ, the only U.S. Food & Drug Administration ("FDA") approved product indicated to reduce the risk of preterm birth..
Cannabis Science Prepares Release of Second Cannabis-Extract-Based Formulatio
bi13282073
Cannabis Science, Inc. (OTCBB:CBIS), a pioneering US biotech company developing cannabis ..
Metrics' Potent Facility Now Offers Neat API Capsule Filling
bi13282073
Metrics Inc. now offers neat active ingredient (API) capsule filling state-of-the-art potent and cytotoxic facility
NovaDel Reports Financial Results for Third Quarter 2011
bi13282073
NovaDel Pharma Inc. (OTCBB: NVDL), a specialty company that develops oral spray formulations of marketed products, today reported financial results for the quarter ended September 30, 2011. As of September 30, 2011, NovaDel?s cash and cash equivalents were $0.4 million
Cannabis Science Releases First Cannabis-Extract-Based Formulation Available
bi13282073
Cannabis Science, Inc. (OTCBB: CBIS), a pioneering US biotech company developing cannabis products, pleased to announce the successful ..
Independent Laboratory Testing Demonstrates Important Quality Differences Bet
bi13282073
ST. LOUIS, Nov. 8, 2011 /PRNewswire/ -- Recent testing conducted by independent laboratories, commissioned by Ther-Rx Corporation, a subsidiary of K-V Company (the "Company") (NYSE: KV.A/KV.B), shows that multiple samples of both compounded 17P drug formulations and active..
Ps2 Backup Software - Home